Basic

• Nitric Oxide: A Novel Mediator of Inflammation
   
• Maternal Autoantibodies — Pathogenesis of Neonatal Lupus
   
• Function and Pharmacogenomics in Inflammation.
   
• Molecular Mechanism of beta1 Integrin Signal  Transduction
   
• Antigen-binding thresholds for human B cell activation and tolerance.
   
• MAPKs
   

Basic & Clinical Research

Clinical

• Seligman Center for Advanced Therapeutics
   
• Serologically Active, Clinically Stable SLE
   
• Neonatal Lupus National Research Registry
   
• Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA)
   
• For Rheumatoid Arthritis and Osteoarthritis: COX-2 STUDY - A Multicenter, Double-Blind, Parallel Group Study Comparing the Incidence of Clinically Significant Upper GI Adverse Events Associated with Celecoxib (SC-58635) 400 mg bid to that of Ibuprofen 800 mg tid in Patients with OA or RA
   
• A Randomized, Double-Blind, Placebo-Controlled Study of Oral Alendronate Sodium 35 or 10 mg for the Prevention and Treatment of Periprosthetic Osteolysis
   
• A Multi-center, Randomized, Double-blind, Placebo-controlled Study: A Study to Evaluate the Efficacy and Safety of Ketotop ( a topical plaster containing ketoprofen) in the Treatment of Osteoarthritis of the Knee.
   
• A randomized, Double-Blind, Parallel, Multicenter, Placebo-Controlled, Two Year Study:A Study to Determine the Efficacy and Safety of Orally Administered 5 and 15mg/day, and 50mg/week Risedronate in Patients with Medial Compartment Knee Osteoarthritis in North America.